These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Phosphorylation of Akt/GSK-3β/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats. Bharti S, Singh R, Chauhan SS, Hussain T, Al-Attas OS, Arya DS. FEBS Lett; 2012 Jan 20; 586(2):180-5. PubMed ID: 22210189 [Abstract] [Full Text] [Related]
10. [Pharmacological role of HB-EGF shedding by angiotensin II in cardiomyocytes]. Takashima S. Nihon Yakurigaku Zasshi; 2004 Aug 20; 124(2):69-75. PubMed ID: 15277724 [Abstract] [Full Text] [Related]
11. Angiotensin II type 1 receptor-associated protein is an endogenous inhibitor of angiotensin II type 1 receptor action in cardiac hypertrophy: role in check and balance. Zhang Z, Dzau VJ. Hypertension; 2010 May 20; 55(5):1086-7. PubMed ID: 20231520 [No Abstract] [Full Text] [Related]
13. Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6. Ohkura SI, Usui S, Takashima SI, Takuwa N, Yoshioka K, Okamoto Y, Inagaki Y, Sugimoto N, Kitano T, Takamura M, Wada T, Kaneko S, Takuwa Y. PLoS One; 2017 May 20; 12(8):e0182329. PubMed ID: 28771545 [Abstract] [Full Text] [Related]
14. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Zhai P, Galeotti J, Liu J, Holle E, Yu X, Wagner T, Sadoshima J. Circ Res; 2006 Sep 01; 99(5):528-36. PubMed ID: 16902180 [Abstract] [Full Text] [Related]
17. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction. Mori J, Basu R, McLean BA, Das SK, Zhang L, Patel VB, Wagg CS, Kassiri Z, Lopaschuk GD, Oudit GY. Circ Heart Fail; 2012 Jul 01; 5(4):493-503. PubMed ID: 22705769 [Abstract] [Full Text] [Related]
18. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure. Li Y, Takemura G, Okada H, Miyata S, Maruyama R, Esaki M, Kanamori H, Li L, Ogino A, Ohno T, Kondo T, Nakagawa M, Minatoguchi S, Fujiwara T, Fujiwara H. J Card Fail; 2007 Mar 01; 13(2):155-62. PubMed ID: 17395057 [Abstract] [Full Text] [Related]
19. 5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure. Janssen W, Schymura Y, Novoyatleva T, Kojonazarov B, Boehm M, Wietelmann A, Luitel H, Murmann K, Krompiec DR, Tretyn A, Pullamsetti SS, Weissmann N, Seeger W, Ghofrani HA, Schermuly RT. Biomed Res Int; 2015 Mar 01; 2015():438403. PubMed ID: 25667920 [Abstract] [Full Text] [Related]
20. Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor. Kaye DM, Kelly RA, Smith TW. Clin Exp Pharmacol Physiol Suppl; 1996 Mar 01; 3():S136-41. PubMed ID: 8993853 [Abstract] [Full Text] [Related] Page: [Next] [New Search]